A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer
Yen-An Tang, Wei-Ling Wen, Jer-Wei Chang et al. · 2010
Read A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer by Yen-An Tang, Wei-Ling Wen, Jer-Wei Chang et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012417.txt.
Description
Yen-An Tang, Wei-Ling Wen, Jer-Wei Chang and colleagues tested a new drug that blocks gene-reading enzymes in lung cancer cells, in a 2010 PLOS ONE paper. Lung cancer kills more people than any other cancer, and treatment for advanced cases works poorly. The drug targets histone deacetylases, enzymes that tighten DNA packing and silence genes, a strategy already used in some blood cancers.
The new blocker killed lung cancer cells by triggering programmed cell death, wrecking their inner skeleton, and reopening silenced genes. Attacking on three fronts at once may make it harder for tumors to resist. Cell results are only a first step, but they justify animal tests of this compound.
Catalog record
| CREATOR | Yen-An Tang, Wei-Ling Wen, Jer-Wei Chang et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012417